[1]
Nagaraju K, Karthik N, Porchelvan S, Rishi Jain and Snehal Muchhala 2020. An open labelled prospective clinical study to evaluate the efficacy, safety and cost analysis of Pidotimod as add-on drug for maintenance therapy in Paediatric Recurrent Acute Respiratory tract Infections. International Journal of Research in Pharmaceutical Sciences. 11, 2 (Apr. 2020), 2183-2188. DOI:https://doi.org/10.26452/ijrps.v11i2.2167.